1. Home
  2. RVPH vs RFM Comparison

RVPH vs RFM Comparison

Compare RVPH & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • RFM
  • Stock Information
  • Founded
  • RVPH 2006
  • RFM 2020
  • Country
  • RVPH United States
  • RFM United States
  • Employees
  • RVPH N/A
  • RFM N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • RFM Finance/Investors Services
  • Sector
  • RVPH Health Care
  • RFM Finance
  • Exchange
  • RVPH Nasdaq
  • RFM Nasdaq
  • Market Cap
  • RVPH 88.0M
  • RFM 92.3M
  • IPO Year
  • RVPH N/A
  • RFM N/A
  • Fundamental
  • Price
  • RVPH $1.80
  • RFM $15.60
  • Analyst Decision
  • RVPH Strong Buy
  • RFM
  • Analyst Count
  • RVPH 5
  • RFM 0
  • Target Price
  • RVPH $11.40
  • RFM N/A
  • AVG Volume (30 Days)
  • RVPH 1.6M
  • RFM 20.7K
  • Earning Date
  • RVPH 11-14-2024
  • RFM 01-01-0001
  • Dividend Yield
  • RVPH N/A
  • RFM 9.74%
  • EPS Growth
  • RVPH N/A
  • RFM N/A
  • EPS
  • RVPH N/A
  • RFM N/A
  • Revenue
  • RVPH N/A
  • RFM N/A
  • Revenue This Year
  • RVPH N/A
  • RFM N/A
  • Revenue Next Year
  • RVPH N/A
  • RFM N/A
  • P/E Ratio
  • RVPH N/A
  • RFM N/A
  • Revenue Growth
  • RVPH N/A
  • RFM N/A
  • 52 Week Low
  • RVPH $0.60
  • RFM $12.89
  • 52 Week High
  • RVPH $4.50
  • RFM $16.41
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 45.36
  • RFM 58.58
  • Support Level
  • RVPH $1.97
  • RFM $15.44
  • Resistance Level
  • RVPH $2.14
  • RFM $15.74
  • Average True Range (ATR)
  • RVPH 0.16
  • RFM 0.11
  • MACD
  • RVPH -0.02
  • RFM 0.03
  • Stochastic Oscillator
  • RVPH 29.29
  • RFM 67.80

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About RFM RiverNorth Flexible Municipal Income Fund Inc.

RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.

Share on Social Networks: